Champions Oncology, Inc.CSBRNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank29
3Y CAGR-11.7%
5Y CAGR-6.2%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-11.7%/yr
vs -11.0%/yr prior
5Y CAGR
-6.2%/yr
Recent deceleration
Acceleration
-0.7pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 13.54% |
| 2024 | -6.90% |
| 2023 | 9.69% |
| 2022 | 19.66% |
| 2021 | 27.76% |
| 2020 | 18.68% |
| 2019 | 33.72% |
| 2018 | 31.34% |
| 2017 | 37.82% |
| 2016 | 26.16% |